goodmorningvietnam,
GTCB management has ZERO credibility and has demonstrated a complete lack of business acumen. They needed to cut costs at least 2 years ago, but didn't begin doing so until LFB took significant majority control. To my dismay, they kept Cox on board. GTCB has talked about partnerships for a long time and expanding ATYRN markets with CABG or sepsis trials. However, their HORRENDOUS track record means that no price rise will happen until after deals are signed, sealed and delivered with up front money given, and trials actually start.
